Lazard Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Lazard Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,194	Closed	-$61K	–	2632
2022 Q3	$61K	Buy	+1,194	New	+$49.3K	﹤0.01%	1709
2022 Q1	–	Sell	-1,653	Closed	-$60K	–	2604
2021 Q4	$60K	Buy	+1,653	New	+$58K	﹤0.01%	1659
2020 Q4	–	Sell	-145	Closed	-$7K	–	2033
2020 Q3	$7K	Buy	+145	New	+$7.81K	﹤0.01%	1524

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Lazard Asset Management's CCXI Position: Q4 2022 in Review

Lazard Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 1,194 shares — an estimated $61K sold.

Lazard Asset Management first reported a position in CCXI in Q3 2020 and held it in 3 quarters. The position peaked at $61K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Lazard Asset Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Lazard Asset Management sold 1,194 ChemoCentryx, Inc. shares in Q4 2022, an estimated $61K.
Lazard Asset Management first reported a position in ChemoCentryx, Inc. in Q3 2020 and held it in 3 quarters.
Lazard Asset Management's ChemoCentryx, Inc. position peaked at $61K in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Lazard Asset Management's 13F filing for Q4 2022, filed 15 Feb 2023.